Who makes Neu2000KWL High-does group?

Neu2000KWL High-does group is developed by GNT Pharma.

What development phase is Neu2000KWL High-does group in?

Neu2000KWL High-does group is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Neu2000KWL High-does group

GNT Pharma · Phase 2 active Small molecule

At a glance

Generic name	Neu2000KWL High-does group
Also known as	Neu2000KWL is produced by GNT Pharma Pharmaceutical company
Sponsor	GNT Pharma
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Neu2000KWL High-does group CI brief — competitive landscape report
Neu2000KWL High-does group updates RSS · CI watch RSS
GNT Pharma portfolio CI